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Petri Net computational modelling 
of Langerhans cell Interferon 
Regulatory Factor Network predicts 
their role in T cell activation
Marta E. Polak  1,2, Chuin Ying Ung1, Joanna Masapust1, Tom C. Freeman3 & Michael R. 
Ardern-Jones  1
Langerhans cells (LCs) are able to orchestrate adaptive immune responses in the skin by interpreting 
the microenvironmental context in which they encounter foreign substances, but the regulatory 
basis for this has not been established. Utilising systems immunology approaches combining in silico 
modelling of a reconstructed gene regulatory network (GRN) with in vitro validation of the predictions, 
we sought to determine the mechanisms of regulation of immune responses in human primary LCs. The 
key role of Interferon regulatory factors (IRFs) as controllers of the human Langerhans cell response 
to epidermal cytokines was revealed by whole transcriptome analysis. Applying Boolean logic we 
assembled a Petri net-based model of the IRF-GRN which provides molecular pathway predictions for 
the induction of different transcriptional programmes in LCs. In silico simulations performed after model 
parameterisation with transcription factor expression values predicted that human LC activation of 
antigen-specific CD8 T cells would be differentially regulated by epidermal cytokine induction of specific 
IRF-controlled pathways. This was confirmed by in vitro measurement of IFN-γ production by activated 
T cells. As a proof of concept, this approach shows that stochastic modelling of a specific immune 
networks renders transcriptome data valuable for the prediction of functional outcomes of immune 
responses.
In order for the immune system to provide effective defence against pathogens and xenobiotics, it is critically 
important that it discriminates between signals that indicate danger and those which are non-threatening and 
to which a “passive” or “tolerant” response is appropriate. Modulation of immune regulation is of particular 
importance at body surfaces such as skin, where programming the adaptive immune responses takes place1. 
Here a CD1a high, CD207+ subset of cutaneous dendritic cells, Langerhans’ cells (LCs), initiate a rapid immune 
response to an inflammatory signal from the tissue environment2, 3. However, in steady state conditions, LCs 
selectively induce the activation and proliferation of skin-resident regulatory T cells4, 5 that help prevent unwanted 
immune-mediated reactions.
This important balance is impaired in inflammatory skin conditions such as atopic dermatitis (AD), where 
disseminated herpes simplex virus (HSV) infection can be life-threatening without effective treatment6. Recently 
a number of risk factors which may predispose patients with AD to develop eczema herpeticum have been iden-
tified, including filaggrin mutations, high serum IgE levels and reduced levels of IFN type I and II7–9. However, 
the molecular mechanism underpinning the susceptibility to herpes virus infection remains poorly understood. 
Aberrations observed in eczema herpeticum patients point to the importance of impaired anti-viral immune 
response10, diminished activation of CD8+ cytotoxic T cells11, and production of indoleamine 2,3-dioxygenase 
by antigen presenting cells residing in the skin12. We and others have shown, that LCs play a central role in the 
regulation of CD8 T cell-mediated cytotoxic immunity through their unique ability to efficiently cross-present 
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antigens and induce effective CD8 T cell responses2, 3, 13. In atopic disease the ability of skin dendritic cells to 
polarise adaptive immune responses towards Th2 and Th22 through the effect of aberrant cytokine signalling has 
been documented in previous studies1, 14–16. However, little is known of how this signalling affects the ability of 
LCs to induce CD8 T cell function.
A growing body of evidence suggests that the decision processes which control immune activation or toler-
ance are executed via simultaneous signalling through multiple transcription factors interconnected in complex 
molecular networks17, 18. In particular, immune regulation at the transcriptomic level seems to be executed via 
gene regulatory networks (GRN). These provide causal molecular explanations for cellular behaviour and execu-
tion of transcriptomic programmes, as they detail in a directed manner the flow of genomic information and the 
control of cellular outputs19–21.
The ability to comprehensively analyse signalling events in LC GRN is essential for understanding of immune 
regulation in human skin. While it is relatively easy to manipulate the stimulus properties and environmental 
conditions in vitro, the comprehensive assessment of the signalling dynamics in intact human skin is beyond 
the limits of experimental science. Computational modelling offers the most promising way to approach the 
problem, providing the mathematical framework for modelling the resting state of signalling systems, including 
disease-specific steady states, predicting the cell and system behaviour during prolonged exposure to signalling 
stimulus, and the outcome of multiple signalling events19, 22.
Quantitative models, using Michaelis-Menten kinetics-based rate laws23 and mass action kinetic models20, 
have been successfully used for simulating small biological networks. They have provided insights into the mech-
anisms regulating gene, signalling and metabolic regulatory network behaviour. However, the inherent limitation 
of such an approach lies with the requirement for input of detailed kinetic parameters and relationships within 
the network, hence constraining the models to relatively small sized networks. For analysis and modelling of large 
molecular networks, including metabolic networks21, signalling networks24 and gene regulatory networks25, Petri 
nets have recently emerged as a promising tool. The approach allows the user to vary inputs, which then create a 
signal flow through the network based solely on the network connectivity, eliminating the necessity for multiple 
kinetic parameters at each step. The network model was first validated to recapitulate outcomes reported in the 
literature, including dendritic cells and macrophage subsets26–35. Subsequently they have been used to model 
experimental data derived from whole transcriptome analysis of human Langerhans cells.
To understand better the molecular cross-talk between the structural cells and LC orchestrating adaptive 
immune responses, we have applied a bioinformatic analysis of transcriptomics data. This allows network infer-
ence and dynamic simulation of the behaviour of transcription factor networks and experimental validation of 
model predictions. Combining bioinformatics analysis with in vitro experiments has allowed us to characterise 
the differential effect of key epidermal cytokines, TNFα and TSLP, on the ability of LCs to cross-present viral 
antigens to cytotoxic T cells, and to propose a transcriptional mechanism regulating this process.
Results
Epidermal cytokines, TNFα and TSLP, differentially regulate the expression of Interferon 
Regulatory Factors in human migratory LCs. Our recent study documented that TNFα-matured LCs 
express a characteristic molecular signature comprising genes involved in antigen capture, intracellular trafficking 
and formation of immunoproteasome, rendering them superior activators of anti-viral CD8 T cell responses2. To 
analyse how this molecular signature is regulated by signalling from atopic keratinocytes, we measured the whole 
transcriptome expression of the human migratory LCs (85–96% CD1a+/HLA−DR+ (Fig. 1a)) during a time 
course stimulation with TSLP. Bayesian Estimation of Temporal Regulation (BETR)36 identified 870 probesets 
up-regulated at 2 h, 349 up-regulated at 8 h and 280 up-regulated at 24 h of stimulation with TSLP in comparison 
to unstimulated migratory cells. Following exposure to TNFα, probesets up-regulated were 789, 524, and 482 at 
the corresponding time points. TSLP induced down-regulation of 118 probesets (2 h), 618 probesets (8 h) and 
613 probesets (24 h) (compared to 302, 895, and 772 probesets down-regulated by TNFα at the corresponding 
time points, 1 fold difference in log 2(x) robust multichip average (RMA)-normalized expression level between 
the time point and control, BETR p < 0.05). Comparative analysis of whole transcriptome data from human LCs 
matured with TNFα or TSLP defined a core signature of 527 genes as being differentially regulated (maSigPro 
algorithm37, p < 0.05) by the two cytokines (Fig. 1b). A transcript-to-transcript Pearson correlation matrix was 
calculated, a graph constructed in BioLayout Express3D 38 (r = >0.8) and subjected to clustering using Markov 
Clustering Algorithm (MCL)39 with an inflation value set at 1.7 (this controls the granularity of clustering) and 
the smallest cluster size set at 5. The analysis identified 18 clusters, 5 preferentially up-regulated by TNFα. The two 
largest clusters (01 and 02) of genes are involved in induction of immune responses and underpinning the cellu-
lar processing of antigens (Fig. 1b). They included genes encoding proteins involved in antigen capture (CAV1), 
intracellular trafficking (SNX10 and SNX11) and formation of immunoproteasome (PSME2, PSME3, PSMB10), 
(Fig. 1c). The 13 smaller clusters induced preferentially by TSLP included genes involved in kinase signalling, 
peroxisome function and nucleotide metabolism. The full details of gene ontology enrichment of the identified 
clusters are listed in Table 1, p values calculated using 2 way repeated measurement paired ANOVA, for time and 
cytokine variable.
To better understand the gene regulatory networks we analysed the expression modules of co-expressed LC 
genes, and the identified promoter motifs and corresponding transcription factors (TF) which regulate their 
expression. In LCs treated with the two cytokines the differentially regulated genes contained a possible IRF 
binding site STTTCRNTTT as the main binding site enriched in the gene signature (ToppGene40, BH p = 0.0125). 
Analysis of the expression of transcription factors indicated that at T0 ZFP36L1, NFKBIA, and NFKB1 were 
the most highly expressed transcription factors. However, following stimulation of LC with the inflammatory 
cytokine TNFα, there was dramatic up-regulation of IRF1 and IRF8 transcripts (6.7 and 13.5 fold respectively) 
at the earliest time point, BETR, p < 0.001) (Fig. 1d). In agreement with their potential role as mediators of LC 
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responses to TNFα and TSLP, the top differentially regulated TFs were IRF1, IRF4 and IRF8, and IRF transcrip-
tional partners including JUN, ATF3, BATF, BATF3; (assessed both from absolute expression levels and fold 
change difference (Fig. 1d and Supplementary Figure S1)). The dependence of IRF1 and IRF4 expression levels on 
the cytokines present in the tissue microenvironment was further confirmed in LCs migrating from the epider-
mal biopsies exposed to TNFα or TSLP (Fig. 1e).
Stochastic simulation of a logic-based diagram of the IRF gene regulatory network with Petri 
Nets allows recapitulation of dendritic cell- induced T cell polarisation. To regulate the cellular 
functional outcome, IRFs interact in a synergistic or antagonistic manner with other transcription factors and 
adaptor molecules41–44. We hypothesised that these interactions create a gene regulatory network encoding the 
transcriptional programmes in dendritic cells. To address the complexity of the interactions within this GRN, we 
assembled a logic-based diagram to capture the multiple reported interactions between IRFs, IRF transcription 
partners and DNA sequences, orchestrating gene transcription, cell function, and thus, the outcome of immune 
stimulation45, 46 (Supplementary Materials and Methods, Tables S1–S4, Supplementary Figure S2). To identify 
components for the IRF-GRN, a systematic search was performed in PubMed for terms describing involvement 
of IRFs in dendritic cell function, antigen presentation and T cell function (Supplementary Table S1). From the 
618 returned papers, 83 unique original papers were identified, describing regulation of gene expression by IRF 
and their transcription partners (Table S2). The data has been structured into an interaction database containing 
Figure 1. Changes in Langerhans cell core transcriptional network induced by epidermal cytokines are 
associated with a dramatic change in expression of IRF1, 4, and 8. (a) Freshly isolated 48 h migratory human 
LCs are CD1a/HLADRhigh. (b) The core transcriptomic networks of human LCs comprising 17 clusters, 
including 2 biggest clusters (01 and 02) of genes involved in antigen processing. Transcript-to-transcript 
clustering, (BioLayout Express3D, r = 0.85; MCL = 1.7) of 527 probesets differentially regulated during 24 h of 
stimulation with TNFα and TSLP, maSigPro p < 0.05. Lines (edges) represent the similarity between transcript 
expressions; circles (nodes) represent transcripts. Clusters of co-expressed genes are coded by colour. (c) 
Expression profile of clusters 01 (95 genes) and 02 (85 genes) during 24 h stimulation with epidermal cytokines, 
green: TNFα, red: TSLP). (d) Expression changes of IRF1, IRF4 and IRF8 in LC during the time course of 
stimulation with TNFα and TSLP, n = 3 independent skin donors. (e) Differential induction of IRF1 and IRF4 
mRNA by TNFα and TSLP during LC migration from biopsies (qPCR, cells from four 6 mm skin biopsies, n = 6 
in duplicate, mean ± SEM, p < 0.0001 for IRF1 and IRF8, and 0.013 for IRF4, two-way repeated measurements 
paired ANOVA).
www.nature.com/scientificreports/
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entries for: (1) and (2) interaction partners, (3) mode of interaction, (4) DNA sequence, (5) regulated genes, 
(6) biological process. This was subsequently converted into a matrix of Boolean interactions between the net-
work components (Table S3) and computationally modelled using a version of Stochastic Petri Nets (SPN)46. 
For a detailed description of a diagram assembly please refer to Livigni et al.45 and the methods section of this 
manuscript45.
The initial validation of the IRF-GRN was performed using theoretical quantities, where “0” represented lack 
of transcription factor expression, corresponding to a gene knock/out model. In silico simulation using the SPN 
algorithm (initial marking set up as a theoretical value either 0 (null expression) or 100 (expressed gene) for 
all possible combinations of the entry nodes: IRF1, IRF4, IRF8, AP1-binding and ETS-binding) demonstrated 
that the model correctly re-capitulates the observations from multiple experimental systems (Table S2, Fig. 2 
and Figure S2). The data describe the involvement of IRFs and their transcriptional partners in regulation of a 
“stereotypical” antigen presenting cell function of a dendritic cell/macrophage lineage. As shown in Fig. 2b, all 
the conditions outlined have been met by the in silico model of the GRN. As reported by others, induction of 
Th1 responses required expression of either IRF1 alone or a combination of IRF8 and ETS transcriptional part-









gene list for low gene 
number clusters
01 TNFα (p < 0.0001, p = 0.021) 95
immune response 
(p = 0.0051), leukocyte 
activation (p = 0.0051), 
proteasome activator 
complex (p = 0.009)
02 TNFα (p < 0.0001, p = 0.011) 84
Pathways: cell cycle 
(p = 0.008), HIV 
infection (p = 0.012), 
proteasome (p = 0.036), 
cross-presentation 
of soluble exogenous 
antigens (endosomes) 
(p = 0.036),
09 TNFα (p < 0.0001, p = 0.052) 12
regulation of RNA 
splicing (p = 0.015)
17 TNFα (p < 0.0001, p = 0.018) 6
CLIP2, IL1R2, OAF, 
RAB38, TCF7, 
TMEM184C




03 TSLP (p < 0.0001, p = 0.005) 36 no annotation
04 TSLP (p = 0.006, p = 0.001) 25 no annotation
05 TSLP (p < 0.0001, p = 0.019) 25
JUN kinase binding 
(p = 0.027)
06 TSLP (p < 0.0001, p = 0.001) 18
peroxisome proliferator 
activated receptor 
binding (p = 0.017)
07 TSLP (p < 0.0001, p = 0.004) 18 no annotation
08 TSLP (p < 0.0001, p = 0.007) 16
nucleotide transferase 
activity (p = 0.026)
10 TSLP (p < 0.0001, p = ns) 10
nucleotide metabolism 
(p = 0.042)
11 TSLP (p < 0.0001, p = 0.022) 10
mRNA splicing 
(p = 0.025)
12 TSLP (p = 0.0007, p = 0.021) 10
Golgi aparatus 
(p = 0.025)
13 TSLP (p < 0.0001, p = 0.038) 9
transferrin receptor 
activity ((p = 0.001)
14 TSLP (p = 0.0014, p = 0.003) 8
ATP5L, EFHA1, ID2, 
INIP, RECQL, RPS4X, 
TMSB4X, UBL5
15 TSLP (p < 0.0001, p = 0.054) 8
CAMK1D, ELL3, LAP3, 
MLLT4, MPC1, NET1, 
NFE2L3, STOM




Table 1. Gene Ontology enrichment in clusters preferentially induced by TNFα or TSLP signalling.
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of IRF4:ETS29–31 (Th2, Fig. 2b, Table S2) or IRF4:AP-132, 47 (Th17 Fig. 2d, Table S2) binding partners. Likewise, 
the simulation recapitulated a cooperative involvement of IRFs and their transcription partners for induction of 
antigen presentation by MHC class I molecules, resulting in activation of CD8 T lymphocytes (in agreement with 
data from existing literature, Tables S2 and S3)33, 34, 42. It predicted that optimal induction of CD8 T cell activation 
requires signalling via both IRF1 and IRF8 (Fig. 2c)35.
The modulation by epidermal cytokines of LC ability to activate antigen-specific CD8 T cell 
responses is predicted by in silico modelling of IRF-GRN parametrised with experimental 
data. One of the more surprising findings emerging from the initial studies of networks and component inter-
actions in different cell types is the multi-functionality (‘functional pleiotropism’) of signalling networks. This 
suggests that biological networks have evolved to enable passing of biologically distinct information through 
shared channels48. In essence, while the GRN architecture and main components are shared between different cell 
types, the spectrum of output genes regulated by the network varies with the specific cell type. This can be illus-
trated by the fact that although, for Th1-polarising dendritic cells, IRF1-controlled IL12p70 production appears 
established26, 49, we and others have demonstrated that IL12p70 is not produced by human LCs2, 13, 50, 51. This is 
despite the rapid up-regulation of IRF1 transcripts in LCs upon stimulation (Fig. 1d). The presented IRF-GRN 
has been assembled by us based on published data derived from multiple cell types. Therefore, to model the 
IRF-dependent programming within LC we adapted the generic IRF-GRN to represent the interactions reported 
in human primary LCs.
To test the ability of human LC to regulate adaptive immune responses, the GRN model was expanded to 
include all the members of AP-1 and ETS family found to be expressed in human LCs, determined by microarray 
analysis2 (Table S6). Furthermore, the network was enriched in elements representing output genes derived from 
existing IRF1, IRF4, and IRF8 ChiP-seq data (Table S4) and filtered to include only the genes expressed by human 
LCs, as measured by microarray experiments (GSE23618, GSE16395, GSE35340, GSE49475, Fig. 3). A series 
of values representing changing levels of LC gene expression (derived from the microarray data) over the time 
course of stimulation with TNFα or TSLP provided the initial values for all entry nodes (Table S6, Supplementary 
executable model files: http://www.virtuallyimmune.org/irf-grn/). Stochastic simulation of the flow of tokens 
through the network and the assessment of token accumulation in the network output nodes provided in silico 
predictions of the pattern of gene expression in LCs during the time course of stimulation by TNFα and TSLP. It 
also revealed their potential to induce different immune responses. Analysing the patterns of token accumulation 
at the network output nodes identified two distinct programmes of gene expression, “A” and “B”. Programme 
“A” included genes preferentially induced by TNFα after binding of transcription factors to ISRE and “B” com-
prised genes regulated in similar manner by TNFα and TSLP, induced after transcription factor binding to EICE 
Figure 2. Network of IRF and their transcription partners regulates transcriptional programmes of dendritic 
cells. Model of IRF-GRN assembled based on a systematic literature review have been simulated with Signalling 
Petri Nets in BioLayout Express3D. Representative results of in silico simulation of the IRF network, measured at 
each of the output nodes, when IRF1 only (dotted red), IRF8 (blue), IRF4 only (green), IRF4 and AP1-binding 
TF (orange), IRF4 and ETS-binding TF (dotted purple), IRF1 and IRF8 (grey) and IRF1 and IRF4 (turquoise) 
are expressed.
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(Figure S3). The results of simulation experiments correctly predicted whether the gene expression profile, as 
measured experimentally, belonged to programme “A” (genes up-regulated by TNFα) or programme “B” for 34 
out of 50 of the network output genes. Predictions included genes associated with antigen presentation (HLA-A, 
-B, -C, CIITA, HLA-DR), immunoproteasome (PSME1, PSME2, PSMB10), LC activation (CD40), and endocy-
tosis (CAV1) (Fig. 4a–f, Table S5, Supplementary Figure S3). Furthermore, simulation experiments indicated 
that the ability of LCs to present a peptide to CD8 T cells would be altered by the cytokine milieu (TNFα/TSLP), 
which has not previously been reported and was not anticipated. To test the in silico predictions, we have exam-
ined the ability of LC to cross-present antigens to antigen-specific CD8 T lymphocytes, utilising a long peptide 
(30 amino acid) containing the EBV BMLF-1 epitope. This epitope is restricted to HLA-A2 and requires intracel-
lular processing for subsequent cross-presentation into the MHC Class I pathway2, 3. Consistent with the model 
prediction, maturation by TSLP diminished the capacity of LC to cross-present a viral epitope to antigen-specific 
CD8 T cells (Fig. 4g,h, n = 5, p < 0.05, Figure S4) whereas this was enhanced by TNFα.
Subsequently, to test if the model was capable of predicting LC behaviour when they have been exposed 
to signals or perturbations within intact epidermis, we targeted signalling of PI3Kγ. This kinase is highly 
expressed by LC, in contrast to dermal Dendritic Cells2 and is one of the most up-regulated genes induced by 
TSLP (Table 1, Cluster 05). Ex vivo epidermal biopsies were cultured in the presence or absence of AS605240, a 
potent, cell-permeable and ATP-competitive inhibitor of PI3Kγ52 (Figure S5a). Migratory LC (Figure S5b) were 
Figure 3. Network of IRF and their transcription partners underpins biological function of human Langerhans 
cells. Interferon Regulatory Factors gene regulatory network (GRN) in DCs, assembled basing on the systematic 
literature review, depicting IRFs, transcription partners, DNA sequences and transcribed genes arranged 
in columns from left to right. Components of the GRN are represented by rectangles (gene transcripts) and 
triangles (DNA sequences) connected by arrows representing molecular interactions (blue arrow: synergism, 
red arrow: inhibition). Green circle denotes binding. GRN output (i.e. immunological function) is presented 
in octagons on the right side of the diagram. The diagram is drawn in a Petri Net notation, where the 
interacting elements of GRN (nodes, gene transcripts) are interspaced with transitions (vertical black lines, 
and black diamonds). Input nodes: IRF 1, 4, and 8, and transcription partners grouped as ETS or AP-1 family. 
Assumption: IRF can bind with any TP from the ETS family. There are 28 members of ETS family, and 5 AP-1 
binding transcription factors. Only the transcription partners exceeding 150 RMA normalised expression 
level in the human skin LC microarray dataset were included in the diagram. The nodes include (classes: left 
to right, list: top to bottom: Transcription factors: IRF1, IRF8, IRF4, IRF-binding partners: AP-1 family: JUN, 
FOS, BATF, BATF3, ETS family: ELF1, ELF4, ELK1, ELK3, ETS1, ETS2, EHF, ELF2, ETV3, ETV6, GABPA. 
DNA binding sequences: AICE, ISRE, EICE. Output genes: Programme A (bracket indicates output genes 
depicted in a single node): CAV1, ERAP1,2, TAP1, (HLA A-F, B2M), TAP2, TAPBPL, PSME1, PSME2, PSMB10, 
CYBB, (CD40, CD80, CD86), IL15, IL12p40, IFNb, iNOS, IL18. Programme B: IL10, IL33, CD74, LYZ, CIITA, 
PRDM1. Biological processes: Th17 responses, antigen presentation in class I, phagocytosis, Th1 responses, Th2 
responses, antigen presentation in class II. Each interaction has been confirmed by two independent reports in 
myeloid cells. The diagram captures the combinatory nature of immune activation, depending on the levels of 
expression, timing and interactions between the regulatory elements. The flow of the signal through the diagram 
can be modelled mathematically using experimental or theoretical data and visualised in BioLayout Express3D. 
Programmes A (green) and B (red) are controlled by combinatorial binding of IRF-TP to different DNA 
sequences. The detailed diagram can be edited/downloaded from http://www.virtuallyimmune.org/irf-grn/.
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harvested 48 h later from inhibitor exposed and non-exposed biopsies and the LC transcriptome assessed using 
Affymetrix Human Gene ST 1.1 microarrays (n = 2 independent donors).
The in silico simulations, run using normalised transcription levels as the initial marking for IRF-GRN 
input nodes (Table S7), predicted that the ability of LC to induce activation of Th1 but not Th2 responses will 
Figure 4. In silico simulation of GRN predicts changes in expression of genes regulated by IRFs and the 
outcome of T lymphocyte stimulation by LCs. (a–f) Expression levels of PSMB10 (a,b) CD40 (c,d) and PRDM1 
(e,f) predicted in silico (a,c,e) and measured 24 h post in vitro activation of LCs (b,d,f). (g,h) The ability of 
TNFα (black) and TSLP (grey) matured LCs to stimulate antigen-specific CD8+ T cells was simulated in silico 
and measured in ELISpot in vitro assay. (g) Result of in silico simulation of the IRF network, measured at the 
output node when the input nodes are marked as per the gene expression values during LCs stimulation with 
TNFα and TSLP, Signalling Petri Nets: BioLayout Express3D, 100 time blocks, 500 runs. Number of tokens in 
the output node in the 10 final time blocks shown. (h) Activation of antigen-specific CD8+ T cells by TNFα 
(grey) and TSLP (black) matured LCs, pulsed with a long peptide antigen requiring cross-presentation, IFNγ 
production measured in co-culture ELISpot assay, n = 6 in triplicate, mean+/−SE.
www.nature.com/scientificreports/
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be diminished by the inhibitor (Figure S5c,d). To validate the in silico predictions and assess the ability of LC 
to prime and polarise adaptive immune responses, LC were co-cultured with allogeneic naïve CD4 T cells for 6 
days. Secretion of IFNγ and IL-4 by primed T cells was used as a proxy for Th1 and Th2 polarisation (Figure S5e,f, 
n = 6, in triplicate, mean ± SEM shown). As shown in Figure S5, in vitro validation confirmed that the PI3Kγ 
inhibitor reduced the LCs ability to induce Th1 immune responses (p < 0.05). The observed trend in reducing 
production IL-4 was not statistically significant, as predicted in silico.
Discussion
Molecular targeting of key signals in the immune system has already demonstrated significant advances in the 
treatment of human disease including cancer and inflammation. These new therapies depend on targeting single 
molecules or pathways. To date, most such treatments have focused on known effector pathways in immunity 
such as T cell cytokines. However, yet undiscovered potential lies in targeting factors critical to maintenance of 
the aberrant immune responses, for which dendritic cells are likely to hold the key. Here, we proposed to investi-
gate in detail the role of immune regulation at the level of transcriptomic networks in human LCs responding to 
cytokine signals, modelling inflamed epidermis. LCs’ anatomical location in the outermost part of the skin and 
mucosal tissue, combined with their classical capacity for antigen capture, processing and presentation, make a 
strong case for their role as the primary gatekeepers against infection and other exogenous pro-inflammatory 
stimuli. By focusing on a key control element of immune regulation by LCs, we have identified the molecular 
basis for the orchestration of epidermal immunity, which may potentially offer molecular targets for immune 
intervention.
Analysis of transcriptional networks allowed us to identify a set of transcription factors from the Interferon 
Regulatory Factors (IRF) family, as a key GRN operating in human LCs. IRFs are critical regulatory molecules 
for dendritic cell development and function42, 53, 54, as well as for efficient regulation of immune responses to 
infectious pathogens26, 55, 56. The importance of IRFs for tissue homeostasis has been further highlighted by the 
association of the causal disease variants in GWAS studies. Thus, IRF-binding sequences have been linked with 
autoimmunity and inflammatory skin disease57, 58, and their key role in driving the Th2 phenotype dominant in 
asthma and allergic diseases29. IRFs function in a network, interacting in a synergistic or antagonistic manner 
in conjunction with other transcription factors and adaptor molecules, and the subsequent signalling pathway 
determines functional outcome41. Recent years have brought substantial advances in our understanding of GRN 
and their control of cell differentiation and immune function29, 41, 54. However, there is currently a lack of evidence 
to support the application of these advances in the prediction of the outcome of immune stimulation determined 
by specific tissue disease states.
Dissecting the complexity of a GRN experimentally is challenging. However, computational modelling offers 
a promising way to approach the problem. It can provide a mathematical framework for modelling the resting 
state of signalling systems, including disease-specific steady states, predicting the cell and system behavior during 
prolonged exposure to signalling stimulus, and the outcome of multiple signalling events20, 59. Computational 
analysis of high throughput data, resulting in the network inference and dynamical simulation of the behaviour 
of a transcription factor network, has been shown to provide meaningful insights into the mechanisms of signal 
integration within a dendritic cell19, 22.
As predictive modelling of regulatory networks can greatly improve data analysis and data – driven hypothesis 
generation, a broad spectrum of mathematical formalism has been developed, allowing network modelling at 
different levels of detail. Quantitative continuous methods such as ordinary differential equations (ODEs), model 
the rate of change of each component in the network and provide detailed quantitative information regarding the 
networks dynamics60. ODEs can be used for modelling small scale GRN22, 23, 43, 61. For example, Hoffmann’s group 
demonstrates use of ODE in mass action kinetic model of chosen elements of the NFκB molecular network to 
achieve comprehensive characterization of the relationship between the resting state and the cellular response 
to stimulation20, 22, 62. They identified distinct temporal profiles of the activity of the central node kinase IKK or 
transcription factor NFκB61 and modelled the temporal control of the specificity of a response63. However, ODEs 
require comprehensive knowledge of kinetic parameters, which are unknown for most networks, and therefore 
their applicability is limited64–66. Furthermore, ODE modelling is computationally expensive, and therefore not 
suitable for large size networks67.
In contrast, qualitative logic-based models, such as Boolean networks68 and Petri nets25, 45, 69, do not depend on 
quantitative data but rather on the structure of the network along with a set of logical constraints. Qualitative reg-
ulatory networks can be built from local experimental observations or knowledge-based information (gene-gene 
or gene-protein interactions)45, 46, 70. The main advantage of qualitative networks is finite numbers of possible 
states making predictions about the dynamics of biological regulatory systems possible despite the lack of kinetic 
information. Despite being far less reliant on knowledge of rate constants than ODEs, SPN improve the quantifi-
cation of Boolean networks, increasing the level of detail and faithfulness to reality, yet still preserving the ability 
to model large networks with relatively high speed (review: ref. 60). SPNs parametrised with discrete experimen-
tal data allows insights into the trends of molecules’ activity-levels in response to an external stimulus24. In our 
work, application of the SPN formalism, utilizing Boolean logic, allowed us to reconstruct the molecular interac-
tions within a key gene regulatory network.
As with most models, the model proposed here is reductionist in its nature. The link between a gene’s expres-
sion and protein function is subject to complex post-transcriptional/translational regulation, which potentially 
limits the inference of transcriptomics data with respect to functional cellular/tissue outcomes. As a qualitative 
network our model does not include complex relationships between transcription factors and DNA, merely indi-
cating that the interaction takes place. This reflects the combinatorial nature of this process, where interaction 
with any expressed transcriptional partner is theoretically possible, and thus stochastically modeled42, 71. Similarly, 
the model assumes that the expression levels of the output genes directly translate to the protein concentrations, 
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which underpin the interactions with T lymphocytes and cell effector responses. However reductionist, the latter 
assumption has been recently justified by the work of Csardi and colleagues, whose noise-robust analyses reveal 
that mRNA levels explain more than 85% of the variation in steady-state protein levels72.
A reductionist approach was necessary to initiate the modelling and be able to derive a workable diagram of 
the GRN, when cells are stimulated with two opposing, ‘clean’ biological signals, rather than being exposed to 
a complex signalling from whole tissue. This allowed us to correctly predict a previously unreported outcome 
of immune stimulation based on the limited input information from a gene expression experiment in primary 
human LC.
Moreover, our approach not only corroborated the hypothesis that gene regulatory networks are universal 
and can be inferred from analysis of different cell populations, but also allowed correct prediction of an outcome 
of T lymphocyte stimulation by LCs based on the expression values of relatively few network components. As 
further validation of the approach, in silico modelling yielded correct prediction of perturbation of LCs function 
when the cells were exposed to a PI3Kγ inhibitor in the context of the intact epidermis. This prediction relied on 
the assumption that when applied to the whole tissue the PI3Kγ inhibitor interacts directly with LCs. As demon-
strated extensively by others, PI3Kγ, in contrast to isoforms α and β, is preferentially expressed in cells of the 
immune system73–75 and the systemic effect of PI3Kγ inhibition in animal models is observed solely in immune 
cells76. Importantly, evaluation of dendritic cell function in the PI3Kγ−/− mice demonstrated, that the knock-out 
mice had a selective defect in the number of skin LCs77 and showed a defective capacity to mount contact hyper-
sensitivity and delayed-type hypersensitivity reactions77. Therefore, even though the epidermis harbours other 
leukocytes, including tissue-resident T lymphocytes78, which can similarly be affected by the inhibitor, our exper-
iment corroborated the assumption, and demonstrated, that the effect of PI3Kγ inhibition in human epidermis 
can be mediated by LCs.
The low resolution of logic-based models imposes limitations on their predictive power. Nevertheless the pre-
sented work is in line with findings by others24, 46 and confirms that the correct prediction of a network’s dynamic 
behavior can be obtained without need for extensive experimentation and computationally expensive parameter 
estimation.
The comparative analysis of transcriptomics data from human LCs exposed to the contrasting epidermal sig-
nals, TNFα and TSLP, allowed us to determine the transcriptional programmes induced by the two cytokines. It 
has been becoming increasingly clear that in vitro culture can regulate the transcriptome as well as the function 
of cultured cells79–81. The direct comparison of effects of TNFα and TSLP on cells cultured in otherwise identi-
cal conditions allowed us to identify genes differentially regulated by these two cytokines, while the differences 
induced by the culture conditions were removed by the maSigPro algorithm. The most significant differences 
were discovered in the genes encoding the ability of LCs to process and present antigens. Maturation of LCs 
in the presence of TSLP resulted in impaired capacity to activate antigen-specific cytotoxic T cells, compared 
with TNFα-matured LCs. This suggests a role for TSLP in mediating the impaired CD8 T cell responses which 
may be of particular relevance for atopic diseases such as asthma and atopic dermatitis which are characterized 
by pre-disposition to viral infections6, 82–84. Indeed, we and others have shown that LCs are extremely potent 
inducers of efficient CD8 T cell activation and anti-viral immunity2, 3, 13, 85. Even though recent reports suggest 
a role of antigen exchange between LCs and subsets of dermal dendritic cells, the importance of LC has been 
demonstrated in murine and human systems, including their role in mediating anti-HSV immune responses 
through antigen uptake and processing86, 87. Furthermore, in vivo, HSV infections principally target keratinocytes 
(through HSV nectin-1 expression)88, and induce keratinocyte apoptosis in the epidermis. Therefore, in early 
infections, LCs uptake and processing of HSV antigens from apoptotic keratinocytes is likely to be critical.
The proposed model provides a proof of concept, to demonstrate that computational modelling of a specific 
immune network can predict functional outcomes of immune responses based on experimentally derived tran-
scription levels of selected key molecular hubs. Applying this reductionist approach allowed us to determine 
the effect of altered cytokine signalling, as would be found in human epidermis under different conditions, and 
predict the impact on immune responses using easily available data (i.e. gene expression levels).
In this case a high epidermal concentration of TSLP in the milieu of atopic dermatitis would be expected to 
impair skin immunity against viral infection through IRF signalling pathways, which may be relevant to eczema 
herpeticum, and may also provide a further rationale for anti-TSLP therapy, or even targeting of IRF, in suscep-
tible individuals.
The validation of the model has so far been limited to the in vitro approach, allowing investigations of the LC:T 
cell interaction in a controlled system. While allowing ease of manipulation, this system does not reflect complex 
signaling events and cell interactions in vivo. In order to be able to use it for the design and testing of therapeu-
tic perturbations, it would be necessary to characterise the disease-related steady state of LCs, and validate the 
outcome of stimulation predicted by the model at both local (skin) and systemic level, iteratively developing the 
model to correctly represent the observed outcomes.
We envisage that the outlined approach can provide a platform for many future studies of human immunity, 
utilising data from individual transcriptomic analyses to provide predictions of how molecular interventions 
may alter cellular phenotype based on the actual gene expression patterns in an individual. Such comprehensive 
analyses ultimately enable inferring the influence of the disease state on the cellular response to stimulation. This 
in turn can determine the outcome of immune responses in health and in disease, and offers the possibility of 
predictive in silico testing of the effectiveness of therapeutic interventions.
Methods
LC isolation and culture. Skin specimens and blood samples were acquired from healthy individuals after 
obtaining informed written consent with approval by the Southampton and South West Hampshire Research 
Ethics Committee in adherence to Helsinki Guidelines. Primary cutaneous DCs were isolated as described 
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previously (5). Briefly, following dispase (2 U/ml, Gibco, UK) digestion of epidermal sheets, migratory LCs 
were harvested after 48 h culture of epidermal fragments. Low density cells were enriched using density gra-
dient centrifugation (Optiprep 1:4.2, Axis Shield, Norway) and purified with CD1a+ magnetic beads accord-
ing to manufacturer’s protocol (Miltenyi Biotec, UK). Epidermal and dermal DCs were purified with magnetic 
beads according to manufacturer’s protocol (epidermal cells: CD1a+, dermal cells: CD11c+, Milenyi Biotec, 
UK). Cells were assayed for yield and cell viability, and unstimulated cells (time 0, 250,000/cell type/donor) were 
harvested immediately. For analysis of changes in gene expression upon activation, LCs were stimulated with 
TNF-α or TSLP (25 ng/ml, 15 ng/ml respectively, Miltenyi Biotec, UK) for 2, 8 and 24 h (250,000 cells/cell type/
donor/time point). For analysis of epidermal explant culture, epidermal sheets from 6 mm biopsies were cul-
tured with epidermal cytokines as described above, and the RNA was isolated for qRT-PCR gene expression 
gene analysis from the LCs were harvested 48 h later. For pulsing with a nominal CD8+ T cell epitope, LCs were 
incubated with 10 μM of a proGLC peptide, containing 9 aminoacid HLA-A2 restricted EBV-derived epitope 
(FNNFTVSFWLRVPKVSASHLEGLCTLVAML; Peptide Protein Research, UK) for 18 h, with TNFα added at 
6 h, and washed thoroughly before co-culture with T cells. EBV-peptide-specific T cell line was expanded as 
described in detail previously2, 3. For PI3Kγ inhibition human epidermal biopsies (6 mm) were exposed to the 
effects of AS605240 at the non-toxic dose 0.1 uM or 1 μl DMSO (control diluent). Migratory LC were co-cultured 
with allogeneic naïve CD4 T cells. Secretion of IFNγ and IL-4 was measured in an ELISpot experiment as per 
manufacturer protocol, (Mabtech, Sweeden), after 6 days of priming and re-stimulation with phytohemagglutinin 
(PHA) (n = 6, in triplicate).
Microarray data analysis. RNA was isolated using RNeasy mini kits (Qiagen, UK) as per the manufac-
turer’s protocol. RNA concentration and integrity was determined with an Agilent Bioanalyser. All the samples 
had a RIN > 7.0 and were taken forward for labelling. Gene expression analysis was carried out using the Human 
Genome U-219 Affymetrix platform (LC stimulation with cytokines) or Human Gene ST 1.1 Affymetrix plat-
form, Affymetrix ATLAS system, for cell migrating post PI3Kγ inhibition. Expression data were normalised using 
the Robust Multichip Average (RMA) package within the Affymetrix expression console package and annotated. 
After an initial QC check, the data was taken forward for analysis. To identify genes regulated by exposure of LCs 
to TNFα and TSLP, a cutoff threshold 0.05 of Bayesian estimation of temporal regulation36 for genes showing 
×1 log(2)-fold difference between the gene expression level at a given time point and time 0 control. Probesets 
differentially regulated by TNFα and TSLP, were identified using MaSigPro algorithm (24) p < 0.05. Using net-
work analysis tool BioLayout Express3D 38, a transcript-to-transcript correlation matrix was calculated for 527 
probesets fulfilling the criteria above, where each column of data was derived from a different sample (donor/cell 
type/condition) and each row of data represents an individual probeset (25). A non-directional network graph of 
the data was generated for a Pearson correlation coefficient of r ≥ 0.80. In this context, nodes represent individual 
probesets (genes/transcripts) and the edges between them Pearson correlation coefficients between individual 
probesets above the threshold value. The network graph was then clustered into groups of genes sharing similar 
profiles using the MCL algorithm within the BioLayout Express3D tool with an MCL inflation value set to 1.7, as 
reported previously (26). Gene set enrichment analysis was performed using the “functional annotation clus-
tering” tool, (similarity threshold 0.5, multiple linkage threshold 0.5, EASE:1.0 and Benjamini correction) from 
DAVID (27) and ToppGene40 web-based analysis tools and confirmed by detailed direct analysis using Gene 
Expression Atlas (http://www.ebi.ac.uk/gxa/). All microarray data used for these studies are available in GEO, 
Accession No.: TNFα and TSLP: GSE49475. PI3Kγ: GSE94247.
Model Assembly. To identify components for the IRF GRN a systematic search in PubMed was performed, 
as summarised in Table S1. Separate searches have been performed for each combination of terms. From the 
returned papers, 82 unique original papers were identified, describing regulation of gene expression by IRF and 
their transcription partners (Table S2). The experimental findings within each listed reference papers have been 
analysed to identify the stimulus, cell type, biological process controlled by IRF (including lists of genes identi-
fied by ChIP-seq analysis), the interaction partner, and the DNA binding sequence. This information has been 
categorised as the network components: input node, transmission node, output node and mode of interaction.
To facilitate the network assembly, the data has been structured into an interaction database, containing 
entries for: (1) stimulus, (2) interaction partner A, (3) interaction partner B, (4) mode of interaction, (5) DNA 
sequence, (6) gene transcription/biological process. This information is shown in Table S2. The interaction data-
base was sorted and analysed to identify experimental findings validated by multiple reports. To be included 
into the network architecture, the interaction had to be confirmed by two independent reports. If any referenced 
publication reported only part of the information (e.g. only interaction between IRF and transcription partner, 
but not the DNA sequence) the lacking information have been inferred from the complementing reports.
To convert the database of interactions into a Boolean network, a checkerboard of interactions between the 
network elements have been assembled (Table S3), assigning for each interaction gate “and”, where both compo-
nents are essential, “or”, when one of the components is essential or “inhibition”.
The network diagram was constructed using yED (yFiles, Germany) following the mEPN notation46, allowing 
computational modelling of concurrent systems. For a detailed description of a diagram assembly please refer to 
Livigni et al.45. Signalling Petri Nets are an extended application of stochastic Petri nets (SPN) originally described 
by Ruths et al.24. This method integrates elements of a Boolean network simulator with the synchronized Petri net 
model for the network represented using the classic Petri net view of places and transitions. In brief, the signal-
ling Petri Net algorithm models the stochastic ‘flow’ of variable numbers of tokens through the network, solely 
determined by the initial input values and the network architecture. The tokens are assigned to the GRN entry 
transitions, and represent quantities of the biological molecules, in case of the IRF-GRN, the levels of expression 
of the transcript. The amount of tokens assigned at the entry (the network initial marking set-up) can be either 
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theoretical, representing a binary on/off expression levels, corresponding to a biological knock-out situation, or 
derived from biological experiment, and representing the quantity of the transcript measured in cells.
IRF GRN model parametrization and in silico simulations. The network diagram has been drawn in 
a mEPN notation24, 46, allowing computational modelling of concurrent systems. When formerly constructed as 
a bipartite graph, nodes represent biological entities and transitions represent biological interactions. The abun-
dance of a molecule at any given network node can be represented by the placement of tokens. Edges connecting 
the nodes and transitions determine the direction of the token flow through the diagram, representing the pro-
gress of the biological process. The detailed description of network assembly can be found in the Supplementary 
Material and methods. To validate the graph reachability and correct prediction of the postulated biological effect 
in the presence of one or many TF, initial marking (number of tokens in the network entry nodes) has been set 
up as a theoretical value either 0 or 100 for every possible combination of the entry nodes: IRF1, IRF4, IRF8, 
AP1-binding and ETS-binding. To test the network behavior in physiological conditions, the initial marking of 
the SPN has been set as per the levels of expression from microarray data analysis, Table S6. Simulations were 
executed using BioLayout Express3D, 100 time blocks, 500 runs.
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